Table 2 Mortality in Chihuahuas with a recorded cause of death under primary veterinary care at UK practices participating in the VetCompass™ Programme from January 1st to December 31st, 2016 (n = 80)
Grouped-level disorder | Count | Percent | 95% CI |
|---|---|---|---|
Heart disease | 15 | 18.8 | 10.9–29.0 |
Lower respiratory tract disorder | 13 | 16.3 | 8.9–26.2 |
Traumatic injury | 11 | 13.8 | 7.1–23.3 |
Brain disorder | 9 | 11.3 | 5.3–20.3 |
Enteropathy | 5 | 6.3 | 2.1–14.0 |
Poor quality of life | 4 | 5.0 | 1.4–12.3 |
Renal disease | 3 | 3.8 | 0.8–10.6 |
Behaviour disorder | 2 | 2.5 | 0.3–8.7 |
Endocrine disorder | 2 | 2.5 | 0.3–8.7 |
Mass-associated disorder | 2 | 2.5 | 0.3–8.7 |
Urinary system disorder | 2 | 2.5 | 0.3–8.7 |
Abdominal disorder | 1 | 1.3 | 0.0–6.8 |
Adverse reaction to drug | 1 | 1.3 | 0.0–6.8 |
Collapsed | 1 | 1.3 | 0.0–6.8 |
Complication associated with clinical care procedure | 1 | 1.3 | 0.0–6.8 |
Haematopoietic disorder | 1 | 1.3 | 0.0–6.8 |
Hepatopathy | 1 | 1.3 | 0.0–6.8 |
Lethargy | 1 | 1.3 | 0.0–6.8 |
Neoplasia | 1 | 1.3 | 0.0–6.8 |
Pancreatic disorder | 1 | 1.3 | 0.0–6.8 |
Parasite infestation | 1 | 1.3 | 0.0–6.8 |
Skin disorder | 1 | 1.3 | 0.0–6.8 |
Spinal cord disorder | 1 | 1.3 | 0.0–6.8 |